Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Invitae Corporation

NVTANYSE
Healthcare
Medical - Diagnostics & Research
$0.02
$-0.01(-35.59%)
U.S. Market opens in 13h 51m

Invitae Corporation (NVTA) Stock Overview

Explore Invitae Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.4M
P/E Ratio-0.00
EPS (TTM)$-5.36
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

NVTA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Invitae Corporation (NVTA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 5.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
18.75%
1-Month Change
3.83%
3-Month Change
-96.93%
6-Month Change
-97.66%
Year-to-Date (YTD) Change
-96.90%
1-Year Change
-98.64%
3-Year Change
-99.96%
5-Year Change
-99.92%
All-Time (Max) Change
-99.89%

Contact Information

415 374 7782
1400 16th Street, San Francisco, CA, 94103

Company Facts

17,000 Employees
IPO DateFeb 12, 2015
CountryUS

Frequently Asked Questions